Pages that link to "Q69696558"
Jump to navigation
Jump to search
The following pages link to Specificity of vigabatrin for the GABAergic system in human epilepsy (Q69696558):
Displaying 10 items.
- Measuring human brain GABA in vivo: effects of GABA-transaminase inhibition with vigabatrin (Q32066867) (← links)
- Effect of vigabatrin on striatal dopamine receptors: evidence in humans for interactions of GABA and dopamine systems (Q33591417) (← links)
- Pharmacology of Vigabatrin (Q36223272) (← links)
- Vigabatrin. A review of its pharmacodynamic and pharmacokinetic properties, and therapeutic potential in epilepsy and disorders of motor control (Q36676442) (← links)
- Developments in anticonvulsants (Q40465190) (← links)
- The economic effects of introducing vigabatrin, a new antiepileptic medication (Q40968909) (← links)
- Vigabatrin in refractory childhood epilepsy. The Brazilian Multicenter Study. (Q53961469) (← links)
- Effects of vigabatrin on motor potentials evoked with magnetic stimulation (Q73341433) (← links)
- Effect of vigabatrin addition on carbamazepine blood serum levels in patients with epilepsy (Q73663195) (← links)
- Cerebrospinal fluid somatostatin in West syndrome: changes in response to combined treatment with high-dose pyridoxal phosphate and low-dose corticotropin (Q77910626) (← links)